Adverum Biotechnologies Inc. (NASDAQ: ADVM) started the day on January 10, 2022, with a price decrease of -2.38% at $1.64. During the day, the stock rose to $1.68 and sunk to $1.60 before settling in for the price of $1.68 at the close. Taking a more long-term approach, ADVM posted a 52-week range of $1.66-$14.79.
Meanwhile, its Annual Earning per share during the time was 5.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -37.20%. This publicly-traded company’s shares outstanding now amounts to $98.13 million, simultaneously with a float of $96.02 million. The organization now has a market capitalization sitting at $165.75 million. At the time of writing, stock’s 50-day Moving Average stood at $1.9460, while the 200-day Moving Average is $3.3504.
Adverum Biotechnologies Inc. (ADVM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Adverum Biotechnologies Inc.’s current insider ownership accounts for 1.50%, in contrast to 72.70% institutional ownership. According to the most recent insider trade that took place on Dec 09, this organization’s CEO, President and Director bought 14,323 shares at the rate of 1.85, making the entire transaction reach 26,498 in total value, affecting insider ownership by 737,462. Preceding that transaction, on Dec 08, Company’s CEO, President and Director bought 10,677 for 1.79, making the whole transaction’s value amount to 19,112. This particular insider is now the holder of 723,139 in total.
Adverum Biotechnologies Inc. (ADVM) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2021, the organization reported -$0.39 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.37) by -$0.02. This company achieved a return on equity of -38.57. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
Adverum Biotechnologies Inc.’s EPS decrease for this current 12-month fiscal period is -37.20% and is forecasted to reach -1.13 in the upcoming year.
Adverum Biotechnologies Inc. (NASDAQ: ADVM) Trading Performance Indicators
Let’s observe the current performance indicators for Adverum Biotechnologies Inc. (ADVM). It’s Quick Ratio in the last reported quarter now stands at 13.70. The Stock has managed to achieve an average true range (ATR) of 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 22.10.
In the same vein, ADVM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.52, a figure that is expected to reach -0.36 in the next quarter, and analysts are predicting that it will be -1.13 at the market close of one year from today.
Technical Analysis of Adverum Biotechnologies Inc. (ADVM)
If we take a close look at the recent performances of Adverum Biotechnologies Inc. (NASDAQ: ADVM), its last 5-days Average volume was 1.55 million that shows plunge from its year to date volume of 2.44 million. During the previous 9 days, stock’s Stochastic %D was recorded 10.93% While, its Average True Range was 0.1175.
Raw Stochastic average of Adverum Biotechnologies Inc. (ADVM) in the period of the previous 100 days is set at 4.15%, which indicates a major fall in contrast to 9.09% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 60.23% that was higher than 57.95% volatility it exhibited in the past 100-days period.